Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin-Reference-Cited by-同舟云学术

Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin

Published:2004-04 Issue:4 Volume:38 Page:719-719
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Kahri A Juhani¹,Valkonen Miia M²,Vuoristo Matti KE³,Pentikäinen Pertti J⁴

Affiliation:

1. Clinical Lecturer, Senior Consultant, Department of Internal Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, Box 340, 00029 HUS, Finland, fax 358-947-174014,

2. Fellow in Infectious Diseases, Department of Internal Medicine, Helsinki University Central Hospital

3. Department Head, Department of Internal Medicine, Helsinki University Central Hospital

4. Professor (retired), Department of Internal Medicine, Helsinki University Central Hospital

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1345/aph.1D243

Reference5 articles.

1. Managing dyslipidemia in the high-risk patient

2. Current Perspectives on Statins

3. Clinical importance of the cytochromes P450

4. A method for estimating the probability of adverse drug reactions

5. Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations*

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of potential drug interactions in co-prescription of statins and macrolide antibiotics in Croatia during the 14 year period;PHARMAZIE;2021

2. Interaction potential between clarithromycin and individual statins—A systematic review;Basic & Clinical Pharmacology & Toxicology;2019-11-08

The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies

;Therapeutics and Clinical Risk Management;2019-07

4. Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management;Drug Discovery Today;2019-01

5. Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand;Therapeutic Advances in Drug Safety;2019-01